Al­con takes a new look at oph­thalmic phar­ma space and mar­ket­ing, post No­var­tis spin­out and raft of ac­qui­si­tions

When Al­con eye care spun out of No­var­tis as an in­de­pen­dent com­pa­ny, the oph­thal­mol­o­gy phar­ma­ceu­ti­cals busi­ness stayed at the Big Phar­ma. For Al­con, though, it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER